Mydecine Innovations Group (MYCO) Price & Analysis

Q: What was Mydecine Innovations Group’s price range in the past 12 months?

Mydecine Innovations Group lowest stock price was C$0.12 and its highest was C$0.50 in the past 12 months.

Q: What is Mydecine Innovations Group’s market cap?

Mydecine Innovations Group’s market cap is C$222.32K.

Q: When is Mydecine Innovations Group’s upcoming earnings report date?

Mydecine Innovations Group’s upcoming earnings report date is Mar 27, 2026 which is in 112 days.

Q: How were Mydecine Innovations Group’s earnings last quarter?

Mydecine Innovations Group released its earnings results on Nov 17, 2025. The company reported C$0.06 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.06.

Q: Is Mydecine Innovations Group overvalued?

According to Wall Street analysts Mydecine Innovations Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Mydecine Innovations Group pay dividends?

Mydecine Innovations Group does not currently pay dividends.

Q: What is Mydecine Innovations Group’s EPS estimate?

Mydecine Innovations Group’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Mydecine Innovations Group have?

Mydecine Innovations Group has 1,235,108 shares outstanding.

Q: What happened to Mydecine Innovations Group’s price movement after its last earnings report?

Mydecine Innovations Group reported an EPS of C$0.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -25%.

Q: Which hedge fund is a major shareholder of Mydecine Innovations Group?

Currently, no hedge funds are holding shares in TSE:MYCO

Compare

99 Followers

MYCO Stock Chart & Stats

C$0.25

<C$0.01(3.70%)

At close: Oct 05 4:00 PM EDT

C$0.25

<C$0.01(3.70%)

Day’s Range― - ―

52-Week RangeC$0.12 - C$0.50

Previous CloseN/A

Volume181.87K

Average Volume (3M)21.60K

Market Cap

C$222.32K

Enterprise ValueC$7.09M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)1.0

Beta-2.53

Next Earnings

Mar 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.06

Shares Outstanding1,235,108

10 Day Avg. Volume18,610

30 Day Avg. Volume21,599

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Mydecine Innovations Group News

Mydecine Innovations Group Completes Debt Settlements to Strengthen Financial Position

Mydecine Innovations Group ( ($TSE:MYCO) ) has issued an announcement. Mydecine Innovations Group Inc. has successfully completed debt...

2M ago

Mydecine Innovations Group Approves Debt Settlements at Shareholder Meeting

An update from Mydecine Innovations Group ( ($TSE:MYCO) ) is now available. Mydecine Innovations Group announced the results...

2M ago

Mydecine Innovations Group Updates on Financial Filings Amid Cease Trade Order

An announcement from Mydecine Innovations Group ( ($TSE:MYCO) ) is now available. Mydecine Innovations Group has announced an...

5M ago

Mydecine Innovations Group Delays Financial Filings Amid Audit Progress

Mydecine Innovations Group ( ($TSE:MYCO) ) has issued an update. Mydecine Innovations Group Inc. has announced a delay...

6M ago

Mydecine Updates on Annual Financial Statements Delay

Mydecine Innovations Group ( ($TSE:MYCO) ) has issued an update. Mydecine Innovations Group Inc. announced a delay in...

6M ago

Mydecine Innovations Group Delays Annual Financial Filings

Mydecine Innovations Group ( ($TSE:MYCO) ) has provided an update. Mydecine Innovations Group Inc. announced a delay in...

7M ago

Mydecine Innovations Group Faces Audit Delays Amid Financial Constraints

An update from Mydecine Innovations Group ( ($TSE:MYCO) ) is now available. Mydecine Innovations Group has announced a...

7M ago

Mydecine Innovations Group Announces Strategic Board and Management Changes

Mydecine Innovations Group ( ($TSE:MYCO) ) has shared an update. Mydecine Innovations Group has announced significant changes to...

8M ago

Mydecine Shares Suspended on Aquis Market

Mydecine Innovations Group (TSE:MYCO) has released an update. Mydecine Innovations Group, a biotech firm focused on developing treatments...

1y ago

Mydecine Completes Key Financial Filings

Mydecine Innovations Group (TSE:MYCO) has released an update. Mydecine Innovations Group, a biotech firm working on novel mental...

1y ago

MYCO FAQ

What was Mydecine Innovations Group’s price range in the past 12 months?

Mydecine Innovations Group lowest stock price was C$0.12 and its highest was C$0.50 in the past 12 months.

What is Mydecine Innovations Group’s market cap?

Mydecine Innovations Group’s market cap is C$222.32K.

When is Mydecine Innovations Group’s upcoming earnings report date?

Mydecine Innovations Group’s upcoming earnings report date is Mar 27, 2026 which is in 112 days.

How were Mydecine Innovations Group’s earnings last quarter?

Mydecine Innovations Group released its earnings results on Nov 17, 2025. The company reported C$0.06 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.06.

Is Mydecine Innovations Group overvalued?

According to Wall Street analysts Mydecine Innovations Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Mydecine Innovations Group pay dividends?

Mydecine Innovations Group does not currently pay dividends.

What is Mydecine Innovations Group’s EPS estimate?

Mydecine Innovations Group’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mydecine Innovations Group have?

Mydecine Innovations Group has 1,235,108 shares outstanding.

What happened to Mydecine Innovations Group’s price movement after its last earnings report?

Mydecine Innovations Group reported an EPS of C$0.06 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -25%.

Which hedge fund is a major shareholder of Mydecine Innovations Group?

Currently, no hedge funds are holding shares in TSE:MYCO

Company Description

Mydecine Innovations Group

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.